BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18779052)

  • 21. Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.
    Watson-Jones D; Wald A; Celum C; Lingappa J; Weiss HA; Changalucha J; Baisley K; Tanton C; Hayes RJ; Marshak JO; Gladden RG; Koelle DM
    J Clin Microbiol; 2010 Oct; 48(10):3496-503. PubMed ID: 20702659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new acyclic heterodinucleotide active against human immunodeficiency virus and herpes simplex virus.
    Franchetti P; Abu Sheikha G; Cappellacci L; Marchetti S; Grifantini M; Balestra E; Perno C; Benatti U; Brandi G; Rossi L; Magnani M
    Antiviral Res; 2000 Sep; 47(3):149-58. PubMed ID: 10974367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
    Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
    Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel biotinylated lipid prodrugs of acyclovir for the treatment of herpetic keratitis (HK): transporter recognition, tissue stability and antiviral activity.
    Vadlapudi AD; Vadlapatla RK; Earla R; Sirimulla S; Bailey JB; Pal D; Mitra AK
    Pharm Res; 2013 Aug; 30(8):2063-76. PubMed ID: 23657675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The replication of viral and cellular DNA in human herpesvirus 6-infected cells.
    Di Luca D; Katsafanas G; Schirmer EC; Balachandran N; Frenkel N
    Virology; 1990 Mar; 175(1):199-210. PubMed ID: 2155509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations.
    Bernstein DI; Ireland J; Bourne N
    Antiviral Res; 2000 Sep; 47(3):159-69. PubMed ID: 10974368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Avoiding Drug Resistance in HIV Reverse Transcriptase.
    Cilento ME; Kirby KA; Sarafianos SG
    Chem Rev; 2021 Mar; 121(6):3271-3296. PubMed ID: 33507067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A missed point in deciphering the viral synergy between herpes simplex virus and HIV.
    Lisco A; Vanpouille C; Margolis L
    Lancet Infect Dis; 2009 Sep; 9(9):522-3. PubMed ID: 19695487
    [No Abstract]   [Full Text] [Related]  

  • 29. Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus.
    Saijo M; Suzutani T; Itoh K; Hirano Y; Murono K; Nagamine M; Mizuta K; Niikura M; Morikawa S
    J Med Virol; 1999 Aug; 58(4):387-93. PubMed ID: 10421406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic testing of patient herpes simplex virus type 1 and 2 isolates for acyclovir resistance by a novel method based on real-time cell analysis.
    Caliaro O; Barbani MT; Klenja S; Morfin F; Frobert E; Gorgievski M; Steinlin-Schopfer J; Suter-Riniker F
    J Clin Virol; 2020 Apr; 125():104303. PubMed ID: 32163870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A potential anti-HIV-1 compound, Q308, inhibits HSV-2 infection and replication in vitro and in vivo.
    Zhang X; Li A; Li T; Shou Z; Li Y; Qiao X; Zhou R; Zhong X; Li S; Li L
    Biomed Pharmacother; 2023 Jun; 162():114595. PubMed ID: 36989723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
    Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
    J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tailoring acyclovir prodrugs with enhanced antiviral activity: rational design, synthesis, human plasma stability and in vitro evaluation.
    Chayrov RL; Stylos EK; Chatziathanasiadou MV; Chuchkov KN; Tencheva AI; Kostagianni AD; Milkova TS; Angelova AL; Galabov AS; Shishkov SA; Todorov DG; Tzakos AG; Stankova IG
    Amino Acids; 2018 Aug; 50(8):1131-1143. PubMed ID: 29779181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment).
    Joshi P; Prasad VR
    J Virol; 2002 Jul; 76(13):6545-57. PubMed ID: 12050367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity.
    Burrel S; Bonnafous P; Hubacek P; Agut H; Boutolleau D
    Antiviral Res; 2012 Dec; 96(3):386-90. PubMed ID: 23041200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genital herpes due to acyclovir-sensitive herpes simplex virus caused secondary and recurrent herpetic whitlows due to thymidine kinase-deficient/temperature-sensitive virus.
    Shimada Y; Suzuki M; Shirasaki F; Saito E; Sogo K; Hasegawa M; Takehara K; Phromjai J; Chuhjo T; Shiraki K
    J Med Virol; 2007 Nov; 79(11):1731-40. PubMed ID: 17854045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infection.
    Kim HN; Wang J; Hughes J; Coombs R; Sanchez J; Reid S; Delany-Moretlwe S; Cowan F; Fuchs J; Eshleman SH; Khaki L; McMahon MA; Siliciano RF; Wald A; Celum C
    J Infect Dis; 2010 Sep; 202(5):734-8. PubMed ID: 20649426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation.
    Lisco A; Grivel JC; Biancotto A; Vanpouille C; Origgi F; Malnati MS; Schols D; Lusso P; Margolis LB
    J Virol; 2007 Jan; 81(2):708-17. PubMed ID: 17065205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of metal complexes of acyclovir and its acetylated derivative on Herpes simplex virus 1 and Herpes simplex virus 2 replication.
    Varadinova T; Vilhelmova N; Badenas F; Terrón A; Fiol J; Garcia-Raso A; Genova P
    Acta Virol; 2005; 49(4):251-60. PubMed ID: 16402682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acyclovir inhibits Cyprinid herpesvirus 3 multiplication in vitro.
    Troszok A; Kolek L; Szczygieł J; Wawrzeczko J; Borzym E; Reichert M; Kamińska T; Ostrowski T; Jurecka P; Adamek M; Rakus K; Irnazarow I
    J Fish Dis; 2018 Nov; 41(11):1709-1718. PubMed ID: 30144085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.